Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




The Doctor of Nursing Practice: Recognizing a Need or Graying the Line Between Doctor and Nurse?
Link ID 10294
Title The Doctor of Nursing Practice: Recognizing a Need or Graying the Line Between Doctor and Nurse?
Url http://www.medscape.com/viewarticle/582269?src=rss
Description A critical review of the push to require advanced practice nurses to obtain a practice doctorate. An argument against mandating a practice doctorate for advanced nursing practice.
The Medscape Journal of Medicine
Category Articles > Business of Medicine
Keywords
Date Nov 5, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 5.00 (out of 5)
Number of ratings: 2 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. CDC Commentary -- 2009 H1N1: Who Should Receive Antiviral Therapy?
  In this video blog, Anthony Fiore, MD, MPH, offers guidance on which patients are at highest risk for H1N1 influenza and when to prescribe antiviral therapy. Centers for Disease Control and Prevention (CDC)
Category:   Articles > Business of Medicine


2. First Molecular Test Cleared for HSV-1 and HSV-2
  The FDA has granted 510(k) market clearance for a HSV-1 and HSV-2 PCR kit. Medscape Medical News
Category:   Articles > Business of Medicine


3. Pfizer Licenses apoA-I Milano to the Medicines Company
  The Medicines Company has acquired from Pfizer exclusive worldwide licensing of apoA-I Milano, the naturally occurring variant of a protein found in high-density-lipoprotein cholesterol. Heartwire
Category:   Articles > Business of Medicine


4. Schering, Merck Shares Fall on Congressional Probe
  Shares of Schering-Plough Corp and Merck & Co were down on Wednesday after U.S. lawmakers said they would look into allegations that the drugmakers were withholding data from a study of their shared cholesterol medicine Vytorin. Reuters Health Information
Category:   Articles > Business of Medicine


5. FDA Advisory Committee Votes Against Flibanserin for Hypoactive Sexual Disorder
  The Reproductive Health Drugs Advisory Committee voted 10 to 1 on June 18 that flibanserin, 100 mg, was not significantly better than placebo for hypoactive sexual desire disorder. Medscape Medical News
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS